Nanoparticle-based drug delivery systems: What can they really do in vivo?

Abstract excerpt

In the past few decades, there has been explosive growth in the construction of nanoparticle-based drug delivery systems (NDDSs), namely nanomedicines, owing to their unique properties compared with traditional drug formulations. However, because of a variety of challenges, few nanomedicines are on sale in the market or undergoing clinical trial at present. Thus, it is essential to look back and re-evaluate what t...

Topics

Open a Topic to create a Post that cites this publication.

• Animal Virus Infections Studies
• Drug Delivery Systems
• ErbB Receptors
• Lung Neoplasms
• Mutation
• Protein Kinase Inhibitors
• RNA Interference and Gene Delivery
• Tyrosine Kinase Inhibitors

Identifiers and source

Literature Corpus work

e2faede0-1042-5b22-8e52-012d5ab848ce

DOI

10.12688/f1000research.9690.1